注射用炎琥宁与α-干扰素治疗小儿上呼吸道感染的临床观察

注射用炎琥宁与α-干扰素治疗小儿上呼吸道感染的

目的观察探讨注射用炎琥宁与α-干扰素(α-INF)治疗小儿上呼吸道感染的临床疗效,总结其临床应用价值。方法选取2010年6月～2011年6月142例上呼吸道感染的患儿,随机分为观察组(使用炎琥宁治疗)和对照组(使用α-INF治疗),各71例,观察比较两组治疗效果,进行统计学分析。结果两组临床症状改善时间比较存在明显差异(P<0.05),具有统计学意义;两组疗效及不良反应比较存在显著性差异(P<0.05),具有统计学意义。结论炎琥宁治疗小儿上呼吸道感染的临床疗效显著,明显优于α-INF治疗效果,能显著改善临床症状及体征,不良反应小,安全性高,值得临床合理推广。

Objective To observe and discuss of Yanhuning injection and interferon（alpha INF） in treating infantile upper respiratory tract infection clinical efficacy,summarize its clinical application value.Methods In our hospital from 2010 June to 2011 June,142 cases of upper respiratory tract infection in children,were randomly divided into the observation group（with treatment） and the control group（the use of alpha INF treatment）,71 cases in each,were compared between the two treatment groups,statistical analysis.Results The two groups of clinical symptoms improved time differences（P0.05）,with statistical significance;two groups of curative effect and adverse reaction exist significant differences（P 0.05）,with statistical significance.Conclusion Treatment of pediatric upper respiratory tract infection clinical curative effect,significantly better than the alpha INF treatment effects,can significantly improve the clinical symptoms and signs,undesirable reaction is little,high safety,is worth the clinical reasonable promotion.